As Documents are published they will be made available below.



We deliver VALUE to our shareholders:

  • Preserve equity when business or financial milestones are in sight,
  • Maintain a stream of late stage products,
  • Faster availability of capital through partnership,
  • Low risk products as being in phase I, II and III,
  • A stream of revenue from milestone and royalties.


INFORMATION ABOUT LATEST DEVELOPMENTS WILL BE PRESENTED HERE WHEN AVAILABLE

Players

Second only to defense spending in North America the medicare represents the single biggest expenditure for the governments. With the baby boomers aging population and ever increasing cost of drugs, the pharmaceutical industry have been flourished with an astonishing high revenue income. These companies have massed a market capitalization of billions and increasing continuously.

  Company Ticker Market Cap. ($ Billions)  
         
  Pfizer PFE $ 111 B  
  Merck MRK $ 67 B  
  J&J JNJ $ 167 B  
  Lilly LLY $ 37 B  
  Amgen AMGN $ 61 B  
  Biogen BIIB $ 15 B  

Projects Highlights

Product X-Excite - Sex

This product is a sublingual version of an existing anti erectile dysfunction druge in lage stage development

Product Nico-Z - Addiction

This product is a sublingual version of an existing anti addiction product against a wide range of drug abuse.

Product T-Slim - Obesity

This product is a sublingual version of an appetite lowering drug in early stages of development .